CLASS I Device recall · Reported 5 Jun 2013 · FDA Enforcement Report
EZ Breathe Atomizer recalled by Nephron Pharmaceuticals
Nephron Pharmaceuticals is recalling EZ Breathe Atomizer, distributed nationwide in the US. The recall was initiated on 30 Apr 2013 and the FDA has classified it as Class I.
Check your package
Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.
Recall details
- Recall number
- Z-1371-2013
- FDA event ID
- 65070
- Recalling firm
- Nephron Pharmaceuticals, Orlando, FL
- Classification
- Class I
- Status
- Terminated
- Recall initiated
- 30 Apr 2013
- FDA classified
- 29 May 2013
- Reported
- 5 Jun 2013
- Type
- Voluntary: Firm initiated
- Customers notified by
- Letter
- Reason category
- Choking Hazard
- Device type
- CPAP & Ventilators
Timeline
| 30 Apr 2013 | Recall initiated by company | |
| 29 May 2013 | Classified by FDA | +29 days |
| 5 Jun 2013 | Published in enforcement report | +7 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Possible dislodgement of the "Plate A", if this instance occurs, it presents a potential choking hazard.
Product as listed by the FDA
EZ Breathe Atomizer Model # EZ-100. For the delivery of liquid medications for respiratory usage.
Where it was distributed
Worldwide Distribution-USA (nationwide) including DC and Puerto Rico and the states of AL, AZ, CA, CO, CT, FL, IL, IN, IO, GA, KS, KY, LA, MD, MN, MS, MO, NK, NV, NJ, NM, NY, OH, OK, OR, PA, RI, SC, TN , TX, VT, VA, WA, and WV, and the countries of Guatemala, Poland, Panama, and United Kingdom.
Nationwide AlabamaArizonaCaliforniaColoradoConnecticutDistrict of ColumbiaFloridaGeorgiaIllinoisIndianaKansasKentuckyLouisianaMarylandMinnesotaMissouriMississippiNew JerseyNew MexicoNevada
Questions about this recall
Is EZ Breathe Atomizer recalled?
Yes. Nephron Pharmaceuticals recalled EZ Breathe Atomizer on 30 Apr 2013. The recall is Class I and its status is Terminated. Recall number Z-1371-2013.
Why was it recalled?
Possible dislodgement of the "Plate A", if this instance occurs, it presents a potential choking hazard.
Which lots are affected?
Model # EZ-100 Lots # R2029A, R2029B, R2039A, R2042A, R2045A, and R2047A. Atomizer Serial Number Ranges: 1206034476-1206069065 1207003710-1237038299 1207046505-1207081124 1208027421-1208062155 1209000001-1209069179 1209069180-1209069202 1209069203-1209069460 1210000001-1210103680 1210104001-1210104044
Where was it sold?
Worldwide Distribution-USA (nationwide) including DC and Puerto Rico and the states of AL, AZ, CA, CO, CT, FL, IL, IN, IO, GA, KS, KY, LA, MD, MN, MS, MO, NK, NV, NJ, NM, NY, OH, OK, OR, PA, RI, SC, TN , TX, VT, VA, WA, and WV, and the countries of Guatemala, Poland, Panama, and United Kingdom.
What should I do if I have it?
Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.
What does Class I mean?
Class I is the most serious FDA recall category: there is a reasonable probability that using the product will cause serious health consequences or death.
Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
More recalls from Nephron Pharmaceuticals
All 16| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS III | PF-Succinylcholine Chloride Injection, USP 20 mg/mL (200 mg recalled | Nephron Pharmaceuticals | Labeling Errors | Nationwide |
| Drug | CLASS II | PF-Fentanyl Citrate 2 mcg/mL* & Ropivacaine HCl recalled | Nephron Pharmaceuticals | Foreign Material | Nationwide |
| Drug | CLASS II | del Nido Cardioplegia Solution, Single-Dose Container recalled | Nephron Pharmaceuticals | Sterility | Nationwide |
| Drug | CLASS II | PF-Fentanyl Citrate (2 mcg/mL)* & Bupivacaine HCl 9% Sodium recalled | Nephron Pharmaceuticals | Foreign Material | Nationwide |
| Drug | CLASS II | PF-Fentanyl Citrate 2 mcg/mL* & Bupivacaine HCl recalled | Nephron Pharmaceuticals | Foreign Material | Nationwide |
Other CPAP & Ventilators recalls
All 552| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Device | CLASS II | Medline Hudson Rci, Dbd-circuit,Vent,Inspiratory,Heated,Neo recalled | Medline Industries | Device Malfunction | Nationwide |
| Device | CLASS II | Getinge Y Sensor Module, Servo-u, Servo-n recalled | Maquet Critical Care AB | Device Malfunction | Nationwide |
| Device | CLASS II | Biofire Respiratory Panel 1 (RP2.1) recalled by BioFire Diagnostics | BioFire Diagnostics | Other | Nationwide |
| Device | CLASS I | Astral 100/150 Resmed Astral 100/50 is a ventilator system recalled | ResMed | Packaging Defects | Nationwide |
| Device | CLASS I | Breathing circuit set, coaxial recalled by Hamilton Medical AG | Hamilton Medical AG | Device Malfunction | Nationwide |